"Trade name: NIOCH-14. Date of state registration 04.10.2022," the document says.
NIOCH-14 can be used to treat monkeypox patients, it says.
After being introduced into medical practice, NIOCH-14 will be effective against any types of orthopoxviruses, which include the monkeypox virus, Sergey Shchelkunov, chief researcher at Vector's department of genomic research, said earlier.